research, on demand
Follow-up Q&A grounded in this page: price, AI take, research note, recent news, and sector peers. Anonymous, with a daily question cap. Answers are introductory context, not advice.
Sign in to generate research on JULI — Vantis reads the filings, financials, news, and insider activity, and returns a sourced read in about a minute.
No dividend history for this ticker.
Latest results (Q2 2026, ended 30 Jun 2026): revenue ₦68.0M · PAT -₦12.9M · statement
Close-to-close on each filing's session (* filed after hours or on a non-trading day; priced on the next session); 5d and 30d measure from that session's close. History, not a forecast.
Juli Pharmacy Plc will hold its AGM on 24th September 2025 at 11:00 a.m. at the company's Ikeja office. The agenda includes receiving financial statements, re-electing directors, appointing auditors, and electing audit committee members. The register of members will close from 31st August to 4th September 2026.
Sign in to ask VantisResults session 2026-08-13: 0.0% · 5d 0.0% · 30d pending
Sign in to ask VantisResults session 2026-05-04: 0.0% · 5d 0.0% · 30d 0.0%
Sign in to ask Vantisjuli plc's audited financial statements for 2025 show a profit of 20.775m, down from 35.577m in 2024.
Results session 2026-04-01: 0.0% · 5d 0.0% · 30d -0.1%
Sign in to ask Vantisjuli plc reported financial results for the fourth quarter and year ending december 31, 2025, showing a loss of ₦55.8 million for the quarter and ₦55.8 million for the year.
Results session 2026-02-02: 0.0% · 5d 0.0% · 30d 0.0%
Sign in to ask VantisResults session 2025-10-29: 0.0% · 5d 0.0% · 30d 0.0%
Sign in to ask VantisResults session 2025-07-28: 0.0% · 5d 0.0% · 30d +6.4%
Sign in to ask VantisResults session 2025-05-01: 0.0% · 5d 0.0% · 30d 0.0%
Sign in to ask VantisShowing 8 of 13
No director or insider dealing notices on record for JULI. New notices appear here shortly after they're filed on the exchange.
No news for this ticker.
